糖化血紅素測試市場：按類型、方法和最終用戶分類 - COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響 - 2023-2030 年全球預測

全球糖化血紅素檢測市場預計到 2023 年將達到 68,636 萬美元，年複合成長率為 9.94%，預計到 2030 年將出現驚人成長，達到 133,483 萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球糖化血紅素檢測市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.糖化血紅素檢測的全球市場規模與預測是多少？

2.在預測期內，COVID-19對全球糖化血紅素檢測市場的阻礙因素與影響為何？

3. 在預測期內，全球糖化血紅素測試市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球糖化血紅素檢測市場的競爭策略是什麼？

5. 全球糖化血紅素檢測市場的技術趨勢和法律規範是什麼？

6.全球糖化血紅素檢測市場主要廠商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球糖化血紅素檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 全球糖尿病等多種慢性病的發生率正在上升
    • 老年人口的增加增加了生病的可能性
    • 患者自我照護解決方案迅速採用
  • 抑制因素
    • 與糖化血紅蛋白測試設備相關的高成本
  • 機會
    • 家庭醫療保健市場的新需求，如快速診斷測試和 PCOT
    • 持續進行早期診斷和有效疾病管理的研究和開發活動
  • 任務
    • HbA1c 檢測的限制和替代方案的可用性
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 糖化血紅蛋白測試市場：按類型

• 基於實驗室的測試
• 照護端測試

第7章 糖化血紅素檢測市場（依技術）

• 硼酸親和層析
• 直接酶測定
• 高效液相層析
• 檢測法

第8章 糖化血紅素測試市場：依最終用戶分類

• 學術研究所
• 診斷中心
• 醫院

第9章 美洲糖化血紅素檢測市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太地區糖化血紅素檢測市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲糖化血紅素檢測市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Glycated Hemoglobin Testing Market is forecasted to grow significantly, with a projected USD 686.36 million in 2023 at a CAGR of 9.94% and expected to reach a staggering USD 1,334.83 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Glycated Hemoglobin Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Glycated Hemoglobin Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Laboratory Based Tests and Point-Of-Care Test. The Point-Of-Care Test is projected to witness significant market share during forecast period.

Based on Technique, market is studied across Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography, and Immunoassay. The Boronate Affinity Chromatography is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Diagnostic Centers, and Hospitals. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Glycated Hemoglobin Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Glycated Hemoglobin Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Glycated Hemoglobin Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Glycated Hemoglobin Testing Market?

4. What is the competitive strategic window for opportunities in the Global Glycated Hemoglobin Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Glycated Hemoglobin Testing Market?

6. What is the market share of the leading vendors in the Global Glycated Hemoglobin Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Glycated Hemoglobin Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Glycated Hemoglobin Testing Market, by Type, 2022 vs 2030
• 4.3. Glycated Hemoglobin Testing Market, by Technique, 2022 vs 2030
• 4.4. Glycated Hemoglobin Testing Market, by End-User, 2022 vs 2030
• 4.5. Glycated Hemoglobin Testing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of various chronic diseases such as diabetes globally
    • 5.1.1.2. Rising geriatric population leads to higher vulnerability for diseases
    • 5.1.1.3. Rapid adoption attributed to patient self-care solutions
  • 5.1.2. Restraints
    • 5.1.2.1. High cost pertinent to glycated hemoglobin testing equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging demand for home healthcare market such as rapid diagnostic tests and PCOT
    • 5.1.3.2. Ongoing R&D activities for early diagnosis and efficient disease management
  • 5.1.4. Challenges
    • 5.1.4.1. Limitation of HbA1c tests and availability of substitutes
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Glycated Hemoglobin Testing Market, by Type

• 6.1. Introduction
• 6.2. Laboratory Based Tests
• 6.3. Point-Of-Care Test

7. Glycated Hemoglobin Testing Market, by Technique

• 7.1. Introduction
• 7.2. Boronate Affinity Chromatography
• 7.3. Direct Enzymatic Assay
• 7.4. High-Performance Liquid Chromatography
• 7.5. Immunoassay

8. Glycated Hemoglobin Testing Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Diagnostic Centers
• 8.4. Hospitals

9. Americas Glycated Hemoglobin Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Glycated Hemoglobin Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Glycated Hemoglobin Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. GLYCATED HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
• FIGURE 2. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2022 VS 2030
• FIGURE 3. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2022 VS 2030 (%)
• FIGURE 6. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. GLYCATED HEMOGLOBIN TESTING MARKET DYNAMICS
• FIGURE 9. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. GLYCATED HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 8. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY BORONATE AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIRECT ENZYMATIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY , BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 13. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. GLYCATED HEMOGLOBIN TESTING MARKET LICENSE & PRICING